| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 08/18/2004 | EP1446488A2 Regulated nucleic acid expression system |
| 08/18/2004 | EP1446487A1 Mammalian protein phosphatases |
| 08/18/2004 | EP1446486A1 Transgenic organism expressing fungal mrp-like abc transporters |
| 08/18/2004 | EP1446484A1 Nucleotide sequence coding for a modified protein of interest, expression vector and method for obtaining same |
| 08/18/2004 | EP1446482A2 Compositions and methods for making mutations in cell lines and animals |
| 08/18/2004 | EP1446479A1 Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus |
| 08/18/2004 | EP1446478A2 Dimerized growth factor and materials and methods for producing it |
| 08/18/2004 | EP1446426A2 Peptide purification by means of metal ion affinity chromatography |
| 08/18/2004 | EP1446422A2 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same |
| 08/18/2004 | EP1446421A2 Mutated gene from corynebacterium glutamicum |
| 08/18/2004 | EP1446419A2 Therapeutic polypeptides, nucleic acids encoding the same, and methods of use |
| 08/18/2004 | EP1446417A2 Novel epidermal growth factor protein and gene, and methods of use therefor |
| 08/18/2004 | EP1446415A2 Detection and identification of enteric bacteria |
| 08/18/2004 | EP1446130A2 Ehrlichia canis genes and vaccines |
| 08/18/2004 | EP1446012A1 Combination bacteriolytic therapy for the treatment of tumors |
| 08/18/2004 | EP1446007A1 Methods and compositions for targeting underglycosylated proteins across the blood brain barrier |
| 08/18/2004 | EP1446005A2 Cryopreservation of biological materials using pre-chilled protectant |
| 08/18/2004 | EP1307563B1 Nucleotide sequences which code for the lysr2 gene |
| 08/18/2004 | EP1280603B1 Method for the identification, quantification, and visualisation of micro-organisms |
| 08/18/2004 | EP1194562B1 The lactose operon of lactobacillus delbrueckii and its use for controlling gene transcription and/or expression in bacterial cells |
| 08/18/2004 | EP1071747B1 Immortalised cell lines derived from normal human skin tissues |
| 08/18/2004 | EP1062059B1 Bacterium capable of biodegradation of wastes |
| 08/18/2004 | EP1060240B1 Lactobacillus strain |
| 08/18/2004 | EP1053474B1 Method for the determination of prosthetic infections |
| 08/18/2004 | EP0977856B1 Lag-3 splice variants |
| 08/18/2004 | EP0833920B1 Transferrin receptor genes |
| 08/18/2004 | EP0827544B1 Multimeric proteins |
| 08/18/2004 | EP0820507B1 Ndf peptides |
| 08/18/2004 | EP0804587B1 Mutant luciferases |
| 08/18/2004 | EP0471011B2 HUMAN LACTOFERRIN cDNA SEQUENCE |
| 08/18/2004 | CN1522152A Mycoplasma bovis vaccine and methods of reducing pneumonia in animals |
| 08/18/2004 | CN1522113A Capsule containing in vivo cell or tissue |
| 08/18/2004 | CN1521264A Process for preparing serine-rich protein employing cysteine synthase (cysk) gene |
| 08/18/2004 | CN1521262A Two-step method of hydrogen production by biologically photolyzing water using ocean green algae |
| 08/18/2004 | CN1521256A Polyporus umbellatus |
| 08/18/2004 | CN1521255A Making and planting method for honeysuckle microbe bacteria |
| 08/18/2004 | CN1521254A Solid medium and method for culturing entomopathogenic fungi |
| 08/18/2004 | CN1521187A Use and method for preparing high absorbance phycoerythrobilin using pink columnar galaxaura |
| 08/18/2004 | CN1521186A Use and method for preparing high absorbance phycoerythrobilin using helminthocladia |
| 08/18/2004 | CN1521180A Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| 08/18/2004 | CN1521132A Zero-discharge of water glass effluents by alkaline biotreatment techniques |
| 08/18/2004 | CN1162549C Biphase fast culture medium for tubercle bacillus and preparation method thereof |
| 08/18/2004 | CN1162546C Method of constructing genetic engineering organism based on vivo homologous recombination |
| 08/18/2004 | CN1162544C 基因 Gene |
| 08/18/2004 | CN1162540C Alcohol/aldehyde dehydrogenase |
| 08/18/2004 | CN1162538C Method for producing L-phenylalanine |
| 08/18/2004 | CN1162537C Large-scale liquid deep fermentation process for agaricus |
| 08/18/2004 | CN1162536C Preservation method for live bacterial preparation |
| 08/18/2004 | CN1162443C Cellular injury response element and uses thereof |
| 08/18/2004 | CN1162441C Pluraflavin and derivatives thereof, process for their preparation and use thereof |
| 08/18/2004 | CN1162161C Staphylococcus aureus metabolin gel and its preparing process |
| 08/18/2004 | CN1162089C Microecological regulator for livestock and fowl |
| 08/17/2004 | US6777232 Human membrane proteins and polynucleotides encoding the same |
| 08/17/2004 | US6777229 Consisting of genes encoding proteins conferring tetracycline resistance, streptomycin and spectinomycin resistance, and sulfamethoxazole resistance, wherein said genes are obtained from the antibiotic resistance region of plasmid ptet3 |
| 08/17/2004 | US6777218 Subtilase enzymes having an improved wash performance on egg stains |
| 08/17/2004 | US6777212 Microbial process for producing L-ascorbic acid, D-erythorbic acid, and salts thereof |
| 08/17/2004 | US6777210 Method and reagents for inactivating ribonucleases RNase A, RNase I and RNase T1 |
| 08/17/2004 | US6777209 Vectors, cells and processes for pyrimidine deoxyribonucleosides production |
| 08/17/2004 | US6777208 Generating 2'-deoxyribonucleoside; obtain microorganism, transform with vector containing ribonucleotide reductase, express vector, incubate with substrate, recover 2'-deoxyribonucleoside |
| 08/17/2004 | US6777207 Culture product |
| 08/17/2004 | US6777206 Polynucleotide which encodes a cell division polypeptide; for use in the generation of lysine |
| 08/17/2004 | US6777204 Receptor protein and method for diagnosing inflammatory diseases by using the same |
| 08/17/2004 | US6777202 Process for the recombinant production of s-layer proteins in gram-negative host cells |
| 08/17/2004 | US6777179 Drug screening for an antiviral agent, viricides; genetic engineering |
| 08/17/2004 | US6776993 Tuberculosis vaccine |
| 08/17/2004 | CA2325228C Catalytic domain of the human effector cell cycle checkpoint protein kinase, chk1, materials and methods for identification of inhibitors thereof |
| 08/17/2004 | CA2097702C Dermatomycosis vaccine |
| 08/12/2004 | WO2004067731A1 New strains of bifidobacterium having the ability to produce glutamine |
| 08/12/2004 | WO2004067724A2 Methods of identifying and designing cell surface receptor inhibitors |
| 08/12/2004 | WO2004067720A2 Systems and methods for predicting specific genetic loci that affect phenotypic traits |
| 08/12/2004 | WO2004066928A2 Use of mycobacterial vaccines in cd4+ or cd8+ lymphocyte-deficient mammals |
| 08/12/2004 | WO2004054969A3 Sacromastigophoric therapeutic agent delivery system |
| 08/12/2004 | WO2004042003A3 Cell lysis compositions, methods of use, apparatus, and kit |
| 08/12/2004 | WO2004037998A3 Natural promoters for gene expression in c1 metabolizing bacteria |
| 08/12/2004 | WO2004034989A3 Probiotic bacteria |
| 08/12/2004 | WO2004033691A3 Human lipid phosphate phosphatases and uses thereof for treating neuronal diseases |
| 08/12/2004 | WO2004016802A3 Methods and apparatus for preparing and assaying biological samples to determine protein concentration |
| 08/12/2004 | WO2004006857A3 Glanders/meliodosis vaccines |
| 08/12/2004 | WO2003079977A3 Novel compositions and methods in cancer associated with altered expression of mcm3ap |
| 08/12/2004 | WO2003066804A3 Thermus scotoductus nucleic acid polymerases |
| 08/12/2004 | WO2003039484A3 Novel compositions and methods for cancer |
| 08/12/2004 | WO2003037060A3 Compositions and methods for wt1 specific immunotherapy |
| 08/12/2004 | WO2003032913A3 Methods and compositions for targeting proteins across the blood brain barrier |
| 08/12/2004 | WO2003023028A9 Fungal glyoxal oxidases |
| 08/12/2004 | WO2002090504A3 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 08/12/2004 | WO2002077179A8 Leinamycin biosynthesis gene cluster and its components and their uses |
| 08/12/2004 | WO2002057408A3 Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same |
| 08/12/2004 | US20040158891 Comprises nucleotide sequences coding senescence induced hydrolase in antisense orientation for generating plants with prolonged life or shelf life, flowering, reduced fruit spoilage, seed aging and/or reduced yellowing of leaves |
| 08/12/2004 | US20040158044 Comprises polypeptide which binds major histocompatibility complex for use in cancer diagnosis and treatment; antitumor agents |
| 08/12/2004 | US20040158042 Bacillus odysseyi isolate |
| 08/12/2004 | US20040158040 Peptides participating in prionization of heterogenous erf3 |
| 08/12/2004 | US20040157788 production of antibodies containing K light chains, in order to provide high affinity reproducibly |
| 08/12/2004 | US20040157322 Multi-sample fermentor and method of using same |
| 08/12/2004 | US20040157315 for analyzing microorganisms contamination in the food industry, preferably cola beverages; comprises aqueous monobasic potassium phosphate, ammonium chloride, heptahydrate magnesium sulfate, and saccharose |
| 08/12/2004 | US20040157313 Ammonia-oxidizing bacteria |
| 08/12/2004 | US20040157312 capable of conferring resistance to different bacteria used in fermentation processes; genetic engineering |
| 08/12/2004 | US20040157305 obtained from Rhodococcus; biocatalyst; stereospecific alcohol dehydrogenase activity in the oxidation of secondary alcohols or the reduction of ketones |
| 08/12/2004 | US20040157303 Novel Escherichia coli having accession no PTA 1579 and its use to produce polyhydroxybutyrate |
| 08/12/2004 | US20040157302 exhibiting inhibitory activity against lanosterol synthase for preventive and therapeutic agents caused by accumulation of cholesterol in humans and antifungal agents; using streptomyces |
| 08/12/2004 | US20040157301 for in vitro and/or in vivo bioconversion of biomass-based feed stock substrates, (starch, cellulose); does not require gelatinization and/or liquefaction of substrate |